Your browser doesn't support javascript.
loading
Targeting inflammation for the treatment of Diabetic Kidney Disease: a five-compartment mechanistic model.
Hofherr, Alexis; Williams, Julie; Gan, Li-Ming; Söderberg, Magnus; Hansen, Pernille B L; Woollard, Kevin J.
  • Hofherr A; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, AstraZeneca, BioPharmaceuticals R&D, Gothenburg, Sweden. alexis.hofherr@astrazeneca.com.
  • Williams J; Renal Division, Department of Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. alexis.hofherr@astrazeneca.com.
  • Gan LM; Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolic, AstraZeneca, BioPharmaceuticals R&D, Gothenburg, UK.
  • Söderberg M; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, AstraZeneca, BioPharmaceuticals R&D, Gothenburg, Sweden.
  • Hansen PBL; Department of Molecular and Clinical Medicine, Department of Cardiology, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Woollard KJ; Cardiovascular, Renal and Metabolic Safety, Clinical Pharmacology and Safety Sciences, AstraZeneca, BioPharmaceuticals R&D, Gothenburg, Sweden.
BMC Nephrol ; 23(1): 208, 2022 06 13.
Article en En | MEDLINE | ID: mdl-35698028

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article